Development
Nutrien Ltd.
NTR
$55.69
-$0.02-0.04%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -25.86% | -32.77% | -20.18% | -20.74% | 3.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.86% | -32.77% | -20.18% | -20.74% | 3.11% |
| Cost of Revenue | -17.04% | -20.78% | -0.60% | -4.81% | 13.46% |
| Gross Profit | -39.16% | -50.12% | -47.22% | -41.26% | -9.36% |
| SG&A Expenses | 6.81% | -1.00% | -2.99% | -5.87% | -11.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.88% | -59.77% | -44.08% | -62.20% | 31.45% |
| Total Operating Expenses | -11.82% | -20.34% | -2.78% | -8.05% | 9.16% |
| Operating Income | -76.63% | -74.84% | -58.48% | -55.86% | -14.09% |
| Income Before Tax | -94.56% | -91.35% | -80.81% | -59.31% | -6.96% |
| Income Tax Expenses | -127.20% | -80.08% | -60.79% | -61.78% | -5.61% |
| Earnings from Continuing Operations | -84.26% | -94.82% | -87.56% | -58.41% | -7.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 33.33% | -16.67% | 0.00% | 28.57% | 0.00% |
| Net Income | -84.53% | -95.24% | -87.75% | -58.56% | -7.41% |
| EBIT | -76.63% | -74.84% | -58.48% | -55.86% | -14.09% |
| EBITDA | -68.98% | -56.95% | -51.51% | -43.87% | -13.21% |
| EPS Basic | -83.84% | -94.86% | -86.40% | -54.31% | 1.77% |
| Normalized Basic EPS | -87.96% | -88.73% | -58.82% | -54.92% | -7.07% |
| EPS Diluted | -83.77% | -94.90% | -86.36% | -54.24% | 1.39% |
| Normalized Diluted EPS | -87.94% | -88.72% | -58.75% | -54.85% | -7.01% |
| Average Basic Shares Outstanding | -4.31% | -7.54% | -9.94% | -9.31% | -9.02% |
| Average Diluted Shares Outstanding | -4.46% | -7.67% | -10.10% | -9.45% | -9.07% |
| Dividend Per Share | 10.42% | 10.42% | 10.42% | 10.42% | 4.35% |
| Payout Ratio | 5.75% | 20.19% | 7.14% | 1.31% | 0.02% |